Genomic Classifier for Guiding Treatment of Intermediate-Risk Prostate Cancers to Dose-Escalated Image-Guided Radiotherapy Without Hormone Therapy

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2018.08.030
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Evaluation of the Effectiveness of Adding Androgen Deprivation to Modern Dose-Escalated Radiotherapy for Men With Favorable Intermediate-Risk Prostate Cancer

Cancer
Cancer ResearchOncology
2016English

Target Localization and Toxicity in Dose-Escalated Prostate Radiotherapy With Image-Guided Approach Using Daily Planar Kilovoltage Imaging

Technology in Cancer Research and Treatment
MedicineCancer ResearchOncology
2011English

Intermediate Risk Prostate Cancer Patients Treated With Image Guided Hypofractionated Radiation Therapy

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

The Need for Androgen Deprivation Therapy in Patients With Intermediate-Risk Prostate Cancer Treated With Dose-Escalated External Beam Radiation Therapy

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2015English

Image-Guided Therapies for Prostate and Kidney Cancers

World Journal of Urology
Urology
2019English

Clinical Outcomes of Dose-Escalated Radiotherapy for Localised Prostate Cancer: A Single-Institution Experience

In Vivo
BiochemistryMedicineGeneticsPharmacologyMolecular Biology
2020English

Salvage Image-Guided Radiotherapy to the Prostate After Cryotherapy Failure

Advances in Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2018English

Dose Tracking Assessment for Image-Guided Radiotherapy of the Prostate Bed and the Impact on Clinical Workflow

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2017English

Efficacy and Toxicity of Image-Guided Intensity-Modulated Radiation Therapy Combined With Dose-Escalated Brachytherapy for Stage IIB Cervical Cancer

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy